Rein Therapeutics Inc. (RNTX)

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$1.15
Day's range
$1.28

Rein Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VOSS CAPITAL, LLC 08/14/2026 5.26 M $5.47 M   19.91% 17.33%
CABLE CAR CAPITAL LLC 08/14/2026 5.20 M $5.40 M   1,136.90% 17.11%
ADAR1 CAPITAL MANAGEMENT, LLC 08/14/2026 4.50 M $4.68 M   100.00% 14.82%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 3.38 M $3.51 M   238.29% 11.13%
BIOS CAPITAL MANAGEMENT, LP 08/14/2026 2.98 M $3.10 M   50.44% 9.83%
IKARIAN CAPITAL, LLC 08/14/2026 2.95 M $3.07 M   100.00% 9.72%
GREAT POINT PARTNERS LLC 08/14/2026 2.58 M $2.68 M   100.00% 8.48%
CITADEL ADVISORS LLC 09/02/2026 2.44 M $2.54 M   100.00% 8.03%
VELAN CAPITAL INVESTMENT MANAGEMENT LP 08/14/2026 1.70 M $1.77 M   100.00% 5.60%
SENVEST MANAGEMENT, LLC 08/14/2026 1.23 M $1.28 M   433.10% 4.06%
PROSIGHT MANAGEMENT, LP 08/14/2026 1.10 M $1.14 M   167.25% 3.62%
BLEICHROEDER LP 08/13/2026 1.00 M $1.04 M   100.00% 3.29%
BOOTHBAY FUND MANAGEMENT, LLC 08/14/2026 889.45 K $925.03 K   100.00% 2.93%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 733.14 K $762.54 K   112.70% 2.42%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO 08/03/2026 511.61 K $532.07 K   0.00% 1.69%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 382.52 K $397.82 K   147.56% 1.26%
STATE STREET CORP 08/07/2026 379.60 K $394.79 K   400.11% 1.25%
EMPERY ASSET MANAGEMENT, LP 08/11/2026 370.83 K $385.67 K   100.00% 1.22%
SIGMA PLANNING CORP 08/07/2026 353.68 K $367.82 K   1.43% 1.17%
BLACKROCK, INC. 08/07/2026 326.20 K $339.25 K   376.02% 1.07%
TEXAS CAPITAL BANK WEALTH MANAGEMENT SERVICES INC 08/07/2026 300.76 K $312.79 K   9.92% 0.99%
SEQUOIA FINANCIAL ADVISORS, LLC 07/17/2026 250.00 K $260.00 K   100.00% 0.82%
GAGNON SECURITIES LLC 08/05/2026 229.07 K $238.23 K   -4.36% 0.75%
STONEPINE CAPITAL MANAGEMENT, LLC 08/17/2026 218.04 K $226.76 K   100.00% 0.72%
PALOGIC VALUE MANAGEMENT, L.P. 09/09/2026 180.00 K $187.20 K   0.00% 0.59%
NORTHERN TRUST CORP 08/13/2026 159.72 K $166.11 K   149.03% 0.53%
ROCK CREEK GROUP, LP 08/03/2026 125.00 K $130.00 K   0.00% 0.41%
ABS INVESTMENT MANAGEMENT LLC 08/14/2026 125.00 K $130.00 K   100.00% 0.41%
ABS DIRECT EQUITY FUND LLC 08/13/2026 125.00 K $130.00 K   0.00% 0.41%
WARBERG ASSET MANAGEMENT LLC 08/11/2026 99.00 K $100.98 K   100.00% 0.33%
CORSAIR CAPITAL MANAGEMENT, L.P. 08/14/2026 80.00 K $83.20 K   100.00% 0.26%
GOLDMAN SACHS GROUP INC 08/14/2026 79.79 K $82.98 K   100.00% 0.26%
UBS GROUP AG 08/13/2026 57.41 K $59.71 K   5,506.45% 0.19%
MERCER GLOBAL ADVISORS INC /ADV 08/19/2026 50.46 K $52.48 K   42.30% 0.17%
XTX TOPCO LTD 08/14/2026 45.76 K $47.59 K   38.99% 0.15%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 08/12/2026 42.44 K $44.14 K   0.00% 0.14%
AMERICANA PARTNERS, LLC 08/05/2026 41.84 K $43.51 K   53.25% 0.14%
CHICAGO PARTNERS INVESTMENT GROUP LLC 07/30/2026 41.05 K $32.84 K   0.00% 0.14%
PRIME CAPITAL INVESTMENT ADVISORS, LLC 08/05/2026 36.11 K $37.56 K   100.00% 0.12%
STEEL PEAK WEALTH MANAGEMENT LLC 07/13/2026 33.00 K $34.32 K   153.85% 0.11%
QUBE RESEARCH & TECHNOLOGIES LTD 08/14/2026 30.79 K $32.02 K   100.00% 0.10%
SAVANT CAPITAL, LLC 08/10/2026 30.53 K $23.32 K   100.00% 0.10%
ANCORA ADVISORS, LLC 08/14/2026 30.00 K $31.20 K   50.00% 0.10%
MERIDIAN WEALTH ADVISORS, LLC 08/14/2026 28.49 K $29.63 K   0.00% 0.09%
GLEASON GROUP, INC. 07/13/2026 22.39 K $23.29 K   0.00% 0.07%
GLOBAL RETIREMENT PARTNERS, LLC 08/06/2026 19.32 K $20.09 K   100.00% 0.06%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 19.00 K $19.76 K   -22.45% 0.06%
CANE CAPITAL PARTNERS, LLC 08/05/2026 18.00 K $18.72 K   0.00% 0.06%
ANNANDALE CAPITAL, LLC 08/13/2026 15.03 K $16.00 K   0.00% 0.05%
MORGAN STANLEY 08/13/2026 14.32 K $14.89 K   100.00% 0.05%

Rein Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 71 institutional investors and hedge funds held shares of Rein Therapeutics Inc.. The most heavily invested institutionals were:

Voss Capital, LLC: 5.26 M

Cable Car Capital LLC: 5.2 M

ADAR1 Capital Management, LLC: 4.5 M

VANGUARD CAPITAL MANAGEMENT LLC: 3.38 M

BIOS Capital Management, LP: 2.98 M

Ikarian Capital, LLC: 2.95 M

134.55% of Rein Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 42.09 M shares in the last 24 months. This purchase volume represents approximately $50.51 M in transactions.